Intelligence · Clinical Pipeline
Phase I Pipeline Programs
First-in-human and early clinical safety studies in Phase I.
- Programs
- 4,713
Quick answer
NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.
Top sponsors
- BRIGHT MINDS BIOSCIENCES 327 programs
- Takeda 276 programs
- Anaxis Pharma 204 programs
- Chinese Academy of 190 programs
- United Therapeutics Europe 184 programs
- Teva Pharma 154 programs
- First People's Hospital 149 programs
- Regeneron UK 126 programs
- Boehringer Ingelheim 94 programs
- Sunshine Guojian Pharmaceutical 85 programs
- Lakefront Biotherapeutics NV 62 programs
- HOFFMANN-LA ROCHE 58 programs
-
BGM-2121
Chongqing Precision Biotech Co., Ltd
Advanced Solid Tumors
1 trial -
BHV-1300
Biohaven Bioscience Ireland Limited
Graves Disease
1 trial -
BI 1015550, NERANDOMILAST
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
BI 3011441
Boehringer Ingelheim
Solid Tumors, KRAS Mutation
1 trial -
BI 695502
Boehringer Ingelheim
Healthy
1 trial -
BI 765063
Boehringer Ingelheim
Head and Neck Squamous Cell Carcinoma (HNSCC)
1 trial -
BI 905711
Boehringer Ingelheim
Gastrointestinal Neoplasms
1 trial -
BICX104
BRIGHT MINDS BIOSCIENCES INC.
Opioid-use Disorder
1 trial -
BICX104 naltrexone implantable pellet
BRIGHT MINDS BIOSCIENCES INC.
Healthy Adult Male and Female Volunteers
1 trial -
BIIB094
IONIS PHARMACEUTICALS INC
Parkinson's Disease
1 trial -
BIIB115
Biogen
Healthy Volunteer
1 trial -
BIIB122 (DNL151)
Denali Therapeutics
Healthy Volunteers
1 trial -
BIO 300 Oral Powder
United Therapeutics Europe Ltd
Acute Radiation Syndrome
1 trial -
BIOPIN-6 Active Implant with Naltrexone
BRIGHT MINDS BIOSCIENCES INC.
Opioid Use Disorder
1 trial -
BIS-001 ER
SUPERNUS PHARMACEUTICALS, INC.
Epilepsy, Complex Partial
1 trial -
BL-M07D1
Sichuan Baili Pharmaceutical Co.,
Breast Cancer
1 trial -
BMB-101
BRIGHT MINDS BIOSCIENCES INC.
Healthy
1 trial -
BMN 111 administration via Injector Pen
BioMarin Pharmaceutical Australia Pty Ltd
Achondroplasia
1 trial -
BMN 255
BioMarin Pharmaceutical Australia Pty Ltd
Hyperoxaluria
1 trial -
BMN 349
BioMarin Pharmaceutical Australia Pty Ltd
Alpha 1-Antitrypsin Deficiency
1 trial -
BMP-655/ACS+Standard of care or Standard of care
Pfizer
Rotator Cuff Tear
1 trial -
BMS-641988 (AR#2)
Bristol-Myers Squibb
Prostate Cancer
1 trial -
BMS-906024
Bristol-Myers Squibb
Cancer
1 trial -
BMS-986148
Bristol-Myers Squibb
Advanced Cancer
1 trial -
BMS-986202
Bristol-Myers Squibb
Psoriasis
1 trial -
BMS-986500
Bristol-Myers Squibb
Advanced Solid Tumor
1 trial -
BNT211, BNT211, BNT211, BNT211
BioNTech SE
Solid Tumors
1 trial -
BNT314
BioNTech SE
Advanced or metastatic malignant solid tumors
1 trial -
BPT567
BRIGHT MINDS BIOSCIENCES INC.
Advanced Solid Tumors
1 trial -
BPX-601
Regeneron UK Limited
Metastatic Castration-resistant Prostate Cancer
1 trial -
BPX-601
Regeneron UK Limited
Prostate Cancer
1 trial -
BRI-1501
Yung NA
Gastric Ulcer
1 trial -
BUSPAR® 30 mg Tablet
Teva Pharma GmbH
Healthy
2 trials -
BXCL501 80 Micrograms
BioXcel Therapeutics
Schizophrenia
1 trial -
BZ019
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Large B-cell Lymphoma
1 trial -
Baroreceptor Stimulation
Rhythm Pharmaceuticals Netherlands B.V.
Hypertension
1 trial -
Beamion LUNG-1: A study to test different doses of zongertinib in people with different types of advanced cancer (solid tumours with changes in the HER2 gene)
Boehringer Ingelheim
Solid tumours with HER2 aberrations, Non-small cell lung cancer
1 trial -
Beclomethasone dipropionate BAI
Teva Pharma GmbH
Pharmacokinetics
1 trial -
Behavior Therapy
BRIGHT MINDS BIOSCIENCES INC.
Opiate Dependence
1 trial -
Behavior Therapy-RISE
BRIGHT MINDS BIOSCIENCES INC.
Opioid-Related Disorders
1 trial -
Bemarituzumab
Prime Medicine
Gastrointestinal Cancer
1 trial -
Bemnifosbuvir (BEM)
Atea Pharmaceuticals
Healthy Volunteer Study
2 trials -
Bemnifosbuvir (BEM)
Atea Pharmaceuticals
Healthy Volunteer
1 trial -
Bemnifosbuvir (BEM)/Ruzasvir (RZR) FDC under fasting conditions
Atea Pharmaceuticals
Healthy Volunteer Study
1 trial -
Bemnifosbuvir (BEM)/Ruzasvir (RZR) as a fixed-dose combination
Atea Pharmaceuticals
Healthy Volunteer Study
1 trial -
Bempegaldesleukin
Nektar Therapeutics UK Limited
Covid-19
1 trial -
Bempegaldesleukin (NKTR-214)
Nektar Therapeutics UK Limited
Metastatic Melanoma
1 trial -
Benazepril HCl 40 mg Tablets
Teva Pharma GmbH
Healthy
2 trials
Frequently asked questions
How many Phase I pipeline programs are in the directory?
4,713 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources · All pipeline programs